Literature DB >> 17929111

Update on molecular-targeted therapy in hematologic malignancies.

Takanori Ueda1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17929111     DOI： 10.1007/s10147-007-0709-3

Source DB:  PubMed          Journal:  Int J Clin Oncol        ISSN： 1341-9625            Impact factor:   3.402


× No keyword cloud information.
  4 in total

Review 1.  Modulation of cellular signaling pathways: prospects for targeted therapy in hematological malignancies.

Authors:  Farhad Ravandi; Moshe Talpaz; Zeev Estrov
Journal:  Clin Cancer Res       Date:  2003-02       Impact factor: 12.531

Review 2.  Strategies for optimizing combinations of molecularly targeted anticancer agents.

Authors:  Janet E Dancey; Helen X Chen
Journal:  Nat Rev Drug Discov       Date:  2006-08       Impact factor: 84.694

Review 3.  Molecular targets and the treatment of myeloid leukemia.

Authors:  A Ikeda; D B Shankar; M Watanabe; F Tamanoi; T B Moore; K M Sakamoto
Journal:  Mol Genet Metab       Date:  2006-05-05       Impact factor: 4.797

Review 4.  Advancing the treatment of hematologic malignancies through the development of targeted interventions.

Authors:  Martin S Tallman
Journal:  Semin Hematol       Date:  2002-10       Impact factor: 3.851
  4 in total
  1 in total

1.  Current status of molecular targeted therapy for hematologic malignancies: introduction.

Authors:  Takanori Ueda
Journal:  Int J Clin Oncol       Date:  2013-12-20       Impact factor: 3.402
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.